Reports of the effects of trans fatty acids on coronary heart disease are inconsistent. Trans fatty acids may particularly influence coronary risk when linoleic acid levels are low, a situation which occurs in Scotland where prevalence of coronary heart disease is also very high. The link between trans fatty acid intake and prevalent coronary heart disease was therefore investigated in the Scottish Heart Health Study population.
Reports of the effects of trans fatty acids on coronary heart disease are inconsistent. Trans fatty acids may particularly influence coronary risk when linoleic acid levels are low, a situation which occurs in Scotland where prevalence of coronary heart disease is also very high. The link between trans fatty acid intake and prevalent coronary heart disease was therefore investigated in the Scottish Heart Health Study population.
Trans fatty acid intakes were calculated from 10/359 sets of food-frequency questionnaire data obtained from the crosssectional survey of men and women aged 40-59 years. Logistic regression analysis was used to calculate the odds ratios for prevalent coronary heart disease by fifths of dietary intake of total, natural and commercial hydrogenation-derived trans fatty acid. The group who had undiagnosed coronary heart disease at the time of survey was the pertinent group for examining the possible causative effects of trans fatty acid intake. After adjustment for the confounding factors (i.e. age, weight, height, smoking, level of physical activity, blood pressure, total energy intake and intakes of saturated fat, linoleic acid and the antioxidant vitamins) the odds of undiagnosed coronary heart disease for men, relative to the lowest intake fifth, did not differ significantly from unity by total or commerciallyderived trans fatty acid intake. Odds were around 35% smaller in the higher intake fifths of naturally-derived trans fatty acids. For women, the odds of undiagnosed coronary heart disease tended to be greater in the higher fifths of total (odds ratio 1-36 (95% confidence interval 0-94, 1-89)) and hydrogenated (1-26 (0-92, 1-72)) trans fatty acid relative to the lowest fifth, but only reached significance in the third fifth of total trans fatty acid (1-36 (101, 183) ).
Dietary total and commercially-derived trans fatty acids failed to influence the odds of coronary heart disease for men, even though a significant increase in the ratio of low density plus very low density lipoprotein to high density lipoprotein-cholesterol occurred with trans fatty acid intake. The results, therefore, do not support a major effect of dietary trans fatty acid from commercial hydrogenation on coronary heart disease risk in these Scottish men. The results for women are less clear, and the possibility remains
Introduction
The resurgence of interest in trans fatty acids in relation to health has been fuelled by reports, primarily from the United States, linking trans fatty acid intake to high blood cholesterol 1 '" 51 . It is clearly important to determine whether these associations are equally strong in other countries, such as the U.K., where coronary rates are higher.
The recent evidence from the United States' 81 suggests that trans fatty acids derived from commercially hydrogenated oils used in the manufacture of margarines and shortenings are more 'harmful' with respect to coronary heart disease than those derived naturally from bacterial fermentation in ruminants, and which therefore occur in various meat and dairy products. The different types of trans fatty acid formed by these processes provides the basis for a differential physiological effect. Bacterial fermentation in the rumen is thought to produce primarily trans-11-C18:1 (vaccinic acid), while commercial hydrogenation may primarily produce trans-9 C18:l (elaidic acid) from liquid vegetable oils, and trans-isomers of C 18:1 to C24:l from fish oils' 101 . Elaidic acid may specifically interfere with essential fatty acid (e.g. linoleic acid, C18:2 n-6) metabolism' 1 1! , such that essential fatty acid adequacy may be compromised further in individuals who are already marginally essential fatty acid deficient. Populations, such as the Scots, with a high prevalence of coronary heart disease, and whose risk may be compounded by low linoleic acid intake' 12 ' 131 , may thus be particularly susceptible to trans fatty acid in their diet.
This paper reports the association between commercial hydrogenation-derived (H-) and natural ruminant-derived (N-) trans fatty acids in the diet and prevalence of coronary heart disease in Scotland. The data-base used for this analysis is the baseline Scottish Heart Health Study 1 ' 41 . Due to the cross-sectional nature of these data, prevalent coronary heart disease is divided into the previously diagnosed, and the previously undiagnosed up to the time of the survey, in order to try and overcome the problem of dietary change consequent to diagnosis.
Subjects and methods
The subjects were 10 359 men and women aged 40-59 years who participated in the baseline Scottish Heart Health Study between 1984 and 1986. These people were recruited from General Practitioners' registers across Scotland in 5 year age/sex-stratified bands. Health and socio-demographic details were elicited by questionnaire, and body measurements, a non-fasted blood sample and a 12-lead electrocardiogram recording were obtained at a clinic visit. The full recruitment details and study protocol have been reported previously' 141 . Diet was assessed by a validated semi-quantitative food frequency questionnaire' 15 ' 161 which consisted of 60 questions on the usual frequency of consumption of foods/food groups and family consumption of fats, cheese, milk and sugar. The frequency options were 1-7 days a week, fortnightly, and rarely or never. Alcohol intake was determined by a 7-day recall question.
Trans fatty acid levels were assigned to the food/food groups used in the food-frequency questionnaire based on data from a variety of sources, including the Ministry of Agriculture, Fisheries and Food, published values and 'confidential' product data from industry. Since the survey was carried out in the mid 1980s, care was taken to use trans fatty acid values obtained from food analysis at that time, as far as was possible. Total trans fatty acid values were sub-divided into natural rumen-derived or commercial hydrogenationderived fat. Thus rumen-derived trans fatty acids (Ntrans fatty acid) consisted of the naturally occurring trans fatty acids in meat, meats products, lard, butter and dairy produce, while commercially hydrogenationderived trans fatty acids (H-trans fatty acid) included the trans fatty acids occurring as a result of hydrogenation of vegetable and fish oils which are used in household and commercial margarines and oils for spreading, cooking and baking. No detailed information was available from the food frequency questionnaire regarding the proportion of cooking oil which was reused in deep frying. It was therefore necessary to estimate a value (10% of the total oil consumed) and assign to this an appropriate trans fatty acid level of 35% of total fat' 171 , based on the frequency of fried food consumption in the population. The trans fatty acid values were integrated into the food-frequency questionnaire analysis programme which used the McCance and Widdowson food composition tables' 181 and appropriate updates of the time. (The precise trans fatty acid values set for each item on the food-frequency questionnaire are available from the authors.)
Of the 10 359 men and women who participated in the Scottish Heart Health Study, 164 were excluded from the sub-population analyses of trans fatty acid intake due to missing information regarding the type of spreading fat or cooking oil used. These people were otherwise representative of the whole population.
Grouping of prevalent coronary heart disease
Prevalent coronary heart disease was grouped according to whether the subject reported a previous medical diagnosis of angina or myocardial infarction. These diagnosed groups consisted of 101 cases of myocardial infarction, 136 cases of angina and 132 cases of both, giving a total for men of 369, and for women 34 cases of myocardial infarction, 157 cases of angina and 44 cases 'of both, giving a total of 235. Evidence of previously undiagnosed coronary heart disease was apparent from the Rose chest pain questionnaire (angina or possible myocardial infarction)' 191 or from the 12-lead electrocardiogram recording (Q/QS pattern indicative of myocardial infarction or ST-segment and T-wave changes indicative of ischaemia)'
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. The undiagnosed group for men totalled 659, with the largest two categories being electrocardiogram evidence of ischaemia and possible myocardial infarction from the chest pain questionnaire. For women, the undiagnosed group totalled 795, with the largest two categories being electrocardiogram evidence of ischaemia and angina from the chest pain questionnaire. It is recognized that evidence of ischaemia from electrocardiogram recordings, and angina from the Rose chest pain questionnaire are imprecise measures of coronary heart disease which may result in misclassification, especially for women' .) However, the consensus has been that their inclusion is a valid option which increases the number of cases, and at worst may reduce the magnitude of any effect due to a proportion of 'healthy' individuals being misclassified. Subjects who were asymptomatic for coronary heart disease and not taking any anti-hypertensive, hypocholesterolaemic or potentially coronary-related drugs were classed as the control group (men, n = 3720; women, n = 3749). 
Statistical analysis
The relationship between intakes of trans fatty acid and a range of dietary variables and risk factors for coronary heart disease were examined by Spearman rank correlation. Since trans fatty acids have been reported specifically to affect blood cholesterol levels and, in particular, the low density lipoprotein:high density lipoprotein ratio, this relationship was examined in more detail. Intakes of trans fatty acid (g . day ~ ' and % energy) were divided into fifths, and the mean serum total and high density lipoprotein cholesterol values and the ratio of low density lipoprotein + very low density lipoprotein: high density lipoprotein calculated for each trans fatty acid intake fifth. This was the best proxy for the low density lipoprotein to high density lipoprotein cholesterol ratio. Low density lipoprotein was not measured separately, but is the major component of the combined low density lipoprotein + very low density lipoprotein value.
Mean trans fatty acid intakes were calculated for each sex and coronary heart disease diagnosis group, and differences assessed by analysis of variance. Skewed distributions of intakes were normalized (by logarithm and square root transformation) prior to analysis of variance. The untransformed values are reported in the tables and figures.
Odds ratios and 95% confidence intervals for prevalent diagnosed and undiagnosed coronary heart disease were calculated by intake fifths of trans fatty acid using logistic regression analysis. Tests for linear trends and for residual non-linear effects were carried out. The first analysis was without adjustment and the second adjusted for age, weight, height, cigarette smoking (never, ex-, below 15, 15-14, above 24 per day), physical activity during leisure (subjective assessment of active, moderate or inactive), diastolic blood pressure, total energy intake and intakes of saturated fat, linoleic acid (C18:2 n-6), and antioxidant vitamin C, E and carotenoid consumption (summarized by its first principal component). The lowest intake fifth was designated as the base (odds ratio=l) in each case.
Results
The Spearman rank correlation coefficients between trans fatty acid and coronary heart disease risk factors and dietary variables are reported in Table 1 . The correlation coefficients for the coronary heart disease risk factors are all weak (maximum 018) although many, especially for men, are highly statistically significant. The correlations between the dietary trans fatty acid and other dietary variables are generally far higher (up to 0-88 for saturated fat with N-trans fatty acid for women) and are all in a positive direction, except for the relationship between linoleic acid and N-trans fatty acid (r= -0-15 for men and women).
The mean (SD) trans fatty acid value in each of the intake fifths are given for men and women in Table  2 . For men, 58% of the total trans fatty acid intake of 7-1 g. day"' is due to H-trans fatty acid, while for women, H-trans fatty acid contributes 61% to the mean total trans fatty acid intake of 6-4 g . day" '. The range of total trans fatty acid is from less than 1 g . day ~' to 34 g . day ~' for men and up to 48 g . day ~ ' for women, with the 95th percentiles being 12-7 g. day"' for men and 11 -7 g . day ~' for women. 
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Total, total trans fatty acids, H-trans fatty acid, commercially hydrogenated trans fatty acids; N-trans fatty acid, naturally occurring trans fatty acids (primarily ruminant).
Details of the age-adjusted serum total and high density lipoprotein cholesterol values by fifths of trans fatty acid (as a percent of total dietary energy) are given in Table 3 . Age adjustment did not affect the total or high density lipoprotein-cholesterol values for men, while for women, although age significantly influenced cholesterol values, the slight differences between the unadjusted and adjusted values did not affect the significance of the trends across the trans fatty acid fifths.
Total serum cholesterol levels varied significantly (/><0001) by fifths of N-trans fatty acid for men and women (positive trend) and by fifths of H-trans fatty acid for men (negative trend). High density lipoprotein cholesterol varied inversely with fifths of H-trans fatty acid for men, but was not significantly different for the other groups. The net effect for total-trans fatty acid was an inverse relationship with high density lipoprotein cholesterol for men, and a modest (P-0026) positive relationship with total cholesterol for women.
The effects of these variations in serum cholesterol levels on the ratio of low density lipoprotein + very low density lipoprotein:high density lipoprotein are illustrated in Fig. 1 . The ratio increased significantly across the intake fifths of total and H-trans fatty acid for men (/ ) <0-0001), whilst, for women, the ratio only increased significantly across the fifths of N-trans fatty acid (P=0-001).
Prior to the logistic regression analysis, the mean trans fatty acid intakes in each of the coronary heart disease diagnosis groups were calculated. When trans fatty acid were expressed as g . day " ' total trans fatty acid intakes were highest in the undiagnosed group for men (7-5 g . day" ' vs 7-2 control and 6-4 undiagnosed groups, analysis of variance, f<00001) and for women (6-8 g . day ' vs 6-4 control and 66 diagnosed group, analysis of variance P<00\), and H-trans fatty acid and N-trans fatty acid showed similar trends. No significant differences occurred between the groups when the trans fatty acid intakes were expressed as a percentage of energy.
The results of the logistic regression analysis are shown in Table 4 for men and Table 5 for women. Adjustment for coronary risk factors and the other possible confounders of any trans fatty acid-coronary heart disease relationship frequently altered the significance of the odds ratios and the linear and non-linear trends. For men, the odds of diagnosed coronary heart disease was smaller in the highest intake fifth of H-trans fatty acid and total-trans fatty acid, but nonsignificantly greater in the highest fifths of N-trans fatty acid. Trans-fatty acid intake did not appear to influence odds of diagnosed coronary heart disease in women. Neither was the odds of undiagnosed coronary heart disease for men significantly influenced by total or H-trans fatty acid intake before or after adjustment for the pertinent variables. For N-trans fatty acids, odds of undiagnosed coronary heart disease were significantly lower in the other fifths compared with the lowest. For women, odds of undiagnosed coronary heart disease tended to be higher (36-46%) in the top fifths of total and H-trans fatty acid intake before adjustment. However, the 95% confidence intervals spanned unity for all the adjusted odds ratios except the third fifth of totaltrans fatty acid (odds ratio 1-36, confidence interval
1-01-1-83).

Discussion
In order to discuss these results in relation to previous reports of trans fatty acid and coronary heart disease it is important to understand the limitations and advantages of the different study designs. These results of coronary heart disease prevalence from cross-sectional data cannot be directly compared with the coronary heart disease incidence results from the Nurses Study in the U.S.A.' 81 (where the relative risk of coronary heart disease was 178 (confidence interval 1 12-2-83) in the top fifth of trans-isomers from vegetable fats compared with the bottom fifth), or with the case-control study of myocardial infarction in men and women' 9 ' (which found an increased risk in only the top fifth compared with the bottom fifth for total and vegetable sources of trans fatty acid) since the outcome measures are less precise. The current cross-sectional study does have the advantage of full risk-factor data in a diverse population, as distinct from one occupational group (nurses), and avoids a potential problem in the case-control study 191 of the results being influenced by the retrospective collection of the dietary data (i.e. after infarction) which offers the possibility of dietary change consequent on illness. This problem of the cause-effect relationship between diet and an outcome measure was addressed in the current analysis by separating prevalent coronary heart disease into previously diagnosed and undiagnosed. The aim being that the undiagnosed group would have had no specific advice to change their diet, while Total, total trans fatty acids; H-tFA, commercially hydrogenated trans fatty acids; N-tFA, naturally occurring trans fatty acids (primarily ruminant).
•Odds ratios adjusted for age, weight, height, smoking, physical activity, diastolic blood pressure, total energy intake and intake of saturated fat, linoleic acid and antioxidant vitamins as detailed under statistical methods. Total, total trans fatty acids; H-tFA, commercially hydrogenated trans fatty acids; N-tFA, naturally occurring trans fatty acids (pnmanly ruminant). *Odds ratios adjusted for age, weight, height, smoking, physical activity, diastolic blood pressure, total energy intake and intake of saturated fat, linoleic acid and antioxidant vitamins as detailed under statistical methods. the diagnosed group are likely to have made changes in total energy intake and amount and type of fat [23) , and possibly fibre or fruit and vegetable consumption because of diagnosis. While we have no detailed dietary data on the non-responders (26%), it is known that the prevalence of diagnosed coronary heart disease did not differ from the responders from a short questionnaire which was sent to all non-responders to the full questionnaire and clinical invitation. As such, prevalence bias is unlikely to have seriously confounded the current results. However, the criteria used for assigning people into the undiagnosed group are known to be imperfect 121 '
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, and thus, the undiagnosed group is likely to be a mix of 'healthy' individuals and true coronary heart disease cases who were previously undiagnosed. Hence any differences in risk from trans fatty acid intake are likely to be attenuated, i.e. the minimum possible effect of trans fatty acid intake is reported.
The method of dietary assessment between the three studies is broadly similar, although total energy intake from the Scottish Heart Health Study foodfrequency questionnaire is higher (7 MJ) than in the Nurses Study (5-6 MJ) and it may therefore be more reliable 1241 . Care has been taken to control for all the equivalent and pertinent variables, such as saturated fat, linoleate (C18:2 n-6) and antioxidant vitamin intake, as well as the classic risk factors for coronary heart disease. The statistical adjustment may be even more thorough since smoking groups were more rigorously denned, blood pressure was entered as a continuous variable rather than a binary yes/no to hypertension and a measure of physical activity was included.
Serum cholesterol was not controlled for in the logistic regression analysis, since there is evidence from the current study (Fig. 1) , as well as others' 3 ' 41 to suggest that trans fatty acid may influence the low density lipoprotein:high density lipoprotein ratio and so any effect of trans fatty acid on coronary heart disease risk may be mediated through the change in blood cholesterol. This possibility is borne out for men, since the ratio of low density plus very low density lipoprotein to high density lipoprotein increases significantly across the intake fifths of total and H-trans fatty acid. Ascherio et a/.' 91 proposed an effect of trans fatty acid on coronary heart disease risk independent of cholesterol levels. However, in the present analysis little effect was evident even without controlling for serum cholesterol.
For men, the apparent effect of smaller risk of diagnosed coronary heart disease at the higher intakes of total and H-trans fatty acid, even after controlling for other factors, may be associated with a reduction in total (and therefore trans) fat intake, and possibly other dietary changes such as a change to high polyunsaturated spreads, as a result of diagnosis. This view may be supported by the lack of any such significant effect for women, for it has been observed that women are more resistant to dietary advice7change post-coronary heart disease diagnosis than are men'
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. The odds ratios do also tend to be similar in the diagnosed and undiagnosed groups for women, and not for men.
The odds ratio results for the diagnosed groups appear to confirm (especially for men) that dietary change post-diagnosis interferes with assessment of any true dietary trans fatty acid-coronary heart disease relationship (as has been found previously 1251 ). It is the undiagnosed coronary heart disease groups which may be expected to show any cause-effect relationship between trans fatty acid and prevalent coronary heart disease. If this is the case, then for men, after the pertinent adjustments, the answer is clearly that there is none for total and H-trans fatty acids. For trans fatty acids from natural sources there appears to be a smaller odds of undiagnosed coronary heart disease at higher intakes. In women, these data could possibly be considered to support the view that high total and H-trans fatty acid intake is a risk factor for coronary heart disease, but the effects are by no means conclusive.
Considering the greater range of trans fatty acid intake in this population compared with the Nurses Study 181 (median values for lowest and highest fifths are approximately 3 and 11 g. day"
1 here vs 2-4 and 5-7 g . day" '), one might have expected to see a greater difference in coronary heart disease risk between intake fifths, whereas the effect is far less. This may be partly due to the 'softer' classification of cases (chest pain questionnaire and electrocardiogram) compared with confirmed myocardial infarction and death from coronary heart disease or to the diversity of the Scottish Heart Health Study population with regard to other risk factors which would tend to reduce the importance of a single factor, such as trans fatty acids. Ascherio et a/.
[91 reported a similar wide range of median intakes to the Scottish Heart Health Study, but the trans fatty acid values were far lower. Conceivably a plateau effect occurs, and the intakes of trans fatty acid in this Scottish population are on the plateau, with no change in coronary heart disease risk therefore evident. Against this possibility, are the data from the Euramic study 1261 which show a full range of effects of adipose tissue trans fatty acid levels on myocardial infarction cases in different countries. Risk of myocardial infarction in some countries (Spain and Russia with low and moderate trans fatty acid levels respectively) is significantly lower in the highest trans fatty acid group, whilst in countries with higher levels of trans fatty acid in adipose tissue (Norway and Finland) myocardial infarction risk is significantly greater, or not significantly different (Netherlands and Scotland) between quartiles of adipose tissue trans fatty acids. The Euramic analyses do not adjust for blood pressure, activity or antioxidant vitamins in any form, and inter-country differences in these factors may account for some of the variation. The recent report of Roberts et a/.' 271 also raises the possibility that trans isomers of oleic and linoleic acids may be differently associated with sudden cardiac death. However, overall, the conclusions to be drawn from the present study, and those in the literature, are that: first, it is likely to be inappropriate to consider that trans fatty acid may influence coronary risk equivalently in all populations; second, that even with complex statistical adjustment, it may not be possible to standardize adequately between nations, as so many 'unknown' lifestyle variables may be influencing the clinical outcome differently in different circumstances; and third, the importance of some risk factors (including trans fatty acids?) do appear to differ between the sexes, and this highlights the need for concurrent investigation in men and women.
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